Article
Vertex Pharma misses sales estimates on weak demand for older CF treatments
Rating:
0.0
Views:
87
Likes:
1
Library:
1
Vertex Pharmaceuticals missed Wall Street estimates for third-quarter sales on Monday, hurt by weaker-than-expected demand for its older cystic fibrosis (CF) treatments.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value